Yasmin Side Effects Cause Heart Attack in Healthy Twenty-Somethings
Studies executed on healthy, premenopausal women in the Netherlands determined that Yaz, Yasmin, and Ocella (Yaz generic) suffered an increased risk of venous thrombosis as compared to non-users. The risks were increased as high as fivefold with oral contraceptive pills. These studies were published in August 2009. This was simply the beginning of the contention surrounding Yaz, Yasmin, and Ocella and the accompanying lawsuits to come involving Yaz side effects.
Among the recent disputes surrounding Yasmin, Yaz and Ocella birth control, the contraceptives also contain drospirenone, an element not in other oral contraceptives. The British Medical Journal released studies in August 2009 exhibiting a higher risk of venous blood clots in adult females taking drospirenone as opposed to those who used other oral contraceptives. In the same month, the Food & Drug Administration issued an unconnected advisory to Bayer Pharmaceuticals, makers of Yasmin, for using low-quality batches of drospirenone from a plant in Germany. For the benefit of public interest and well-being, these studies have been made available free on the internet.
Females taking Yasmin, Yaz or Ocella to avoid getting pregnant or to treat PMDD (Premenstrual Dysphoric Disorder) or severe acne have reportedly suffered severe injury to their health and wellbeing. Although not all pharmaceuticals are one-hundred percent safe, the main issue surrounding Yaz seems to be that the original commercials downplayed the health risks and side effects. This attracted users to the product that may not have taken it otherwise had they been properly informed about the risks posed by Ocella, Yasmin and Yaz.
